Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic markers for AIDS.

J J Goedert1

  • 1Viral Epidemiology Section, National Cancer Institute, Bethesda, MD 20892.

Annals of Epidemiology
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Identifying early signs of Acquired Immunodeficiency Syndrome (AIDS) in Human Immunodeficiency Virus (HIV) infected individuals is crucial. Clinical symptoms and specific laboratory markers can predict AIDS development within three years.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A population-based study of the prevalence and risk factors of low-grade Plasmodium falciparum malaria infection in children aged 0-15 years old in northern Tanzania.

Tropical medicine & international health : TM & IH·2019
Same author

Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent.

Genes and immunity·2014
Same author

Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins.

British journal of cancer·2013
Same author

A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2011
Same author

Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls.

British journal of cancer·2011
Same author

Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.

Journal of viral hepatitis·2010
Same journal

Contribution of lifestyle factors to sex differences in educational inequalities in life expectancy in selected European countries.

Annals of epidemiology·2026
Same journal

What remains quantitative in quantitative intersectionality?

Annals of epidemiology·2026
Same journal

Revisiting the role of interaction effects in quantitative intersectionality research.

Annals of epidemiology·2026
Same journal

GLP-1 receptor agonist medications for weight loss: Sociodemographic patterns of awareness, use, and access in a U.S. national cohort.

Annals of epidemiology·2026
Same journal

Even low levels of physical activity are associated with lower all-cause mortality: A cohort study of 594,000 US adults.

Annals of epidemiology·2026
Same journal

Comment on "Distinct differences between COVID-19 vaccine refusers and vaccine hesitant in the United States: Results from a population-based survey and latent class analysis".

Annals of epidemiology·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Immunology
  • Virology

Background:

  • Human Immunodeficiency Virus (HIV) infection can lead to Acquired Immunodeficiency Syndrome (AIDS), characterized by opportunistic infections and malignancies.
  • Prospective cohort studies are essential for understanding HIV progression and identifying predictive markers.

Purpose of the Study:

  • To review the relationship between AIDS and clinical signs, symptoms, immunologic measures, and viral assays.
  • To identify reliable markers for predicting AIDS risk in HIV-infected individuals.

Main Methods:

  • Analysis of data from prospective cohort studies, focusing on clinical and laboratory findings.
  • Evaluation of various clinical signs (oral candidiasis, fever, weight loss) and laboratory assays (CD4+ lymphocyte count, beta 2 microglobulin, neopterin, interferon, HIV-p24 antigen).

Related Experiment Videos

Main Results:

  • Specific clinical signs (oral candidiasis, fever, weight loss) and a CD4+ lymphocyte count below 200 cells/microliter are strong predictors of AIDS risk within 3 years.
  • Elevated beta 2 microglobulin and neopterin levels show promise as predictive markers, requiring further validation in diverse populations.
  • Interferon and HIV-p24 antigen are sensitive but specific markers, potentially offering predictive value independent of CD4+ counts.

Conclusions:

  • Clinical and laboratory markers derived from prospective studies are vital for therapeutic trial decisions and managing HIV infection.
  • Further research and technical simplification of assays like immunoglobulin levels, tumor necrosis factor, soluble interleukin 2, and HIV viremia are needed.
  • Marker data will be invaluable for mathematical modeling of the HIV/AIDS epidemic as effective treatments emerge.